Triumf Health

Triumf Health is a company dedicated to empowering children's mental resilience through innovative, evidence-based gaming. Founded in 2016 and headquartered in Estonia, the company has garnered attention for its flagship product, Triumfland Saga, an evidence-based mental health management game designed for children aged 7-12. With the aim of addressing the onset of mental disorders in children, the company's approach focuses on prevention and promotion, targeting mental health issues at an early age.

The company's emphasis on digital medicine is rooted in its recognition of the importance of early detection of mental illness and the provision of youth-friendly treatment. By leveraging psychosocial research, validated psychological techniques, and data analytics, Triumf Health has developed a Digital Therapeutic (DTx) platform. This platform aims to assess, monitor, and support the mental health of children while fostering healthy habits through gameplay. Notably, the digital intervention is based on the Self-Determination Theory of motivation and behavior change, delivering research-based content in a personalized manner within a game environment.

Triumfland Saga, available in 9 languages, offers a subscription-based model for parents, providing ongoing mental health support for children. Moreover, the company offers annual licenses to educational institutions, hospitals, and governments, providing a cost-effective solution for integrating the mental health game into existing offerings and reaching a larger number of children in need.

In July 2019, Triumf Health secured a Seed Round investment. While the specifics of the investors are not detailed, this investment demonstrates confidence in the company's vision and potential impact in the critical intersection of Education, Gaming, Healthcare, and Information Technology. With its innovative approach to addressing children's mental health, Triumf Health represents an intriguing investment opportunity in the digital health and EdTech sectors.